Original Research
Accepted on 03 Nov 2025
Development of an In Vitro Metabolic Dysfunction-Associated Steatohepatitis Model to Investigate Altered Drug Metabolizing Enzymes, Transport Proteins, and Hepatobiliary Disposition
in Drug Metabolism and Transport